Noteworthy, sCLEC-2 emerges as a pivotal regulator of atherosclerotic thrombosis, whereas human CLEC-2, encoded by CLEC1B, functions as a non-classical C-type lectin receptor. This evidence concerns the gene CLEC1B and deep vein thrombosis.